Cervical Health

Latest News

Reduced cost-effectiveness reported from HPV vaccination in mid-adults | Image Credit: © Tobias Arhelger - © Tobias Arhelger - stock.adobe.com.
Reduced cost-effectiveness reported from HPV vaccination in mid-adults

November 27th 2024

A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.

Contemporary OB/GYN week in review: Endometriosis, ovarian cancer, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.
Contemporary OB/GYN week in review: Endometriosis, ovarian cancer, and more

October 4th 2024

HPV 16 and 18 linked to ovarian cancer risk | Image Credit: © onephoto - © onephoto - stock.adobe.com.
HPV 16 and 18 linked to ovarian cancer risk

October 3rd 2024

US-affiliated HPV vaccination progress from 2013 to 2023 | Image Credit: © Kt Stock - © Kt Stock - stock.adobe.com.
US-affiliated HPV vaccination progress from 2013 to 2023

August 23rd 2024

Contemporary OB/GYN week in review: Abortion restrictions, STI testing, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.
Contemporary OB/GYN week in review: Abortion restrictions, STI testing, and more

August 9th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.